SEC Form SC 13G filed by Biomerica Inc.

2/9/24 3:06:57 PM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Get the next $BMRA alert in real time by email

SC 13G 1 bmra224.txt SCHEDULE 13G Amendment No. Name of Issuer: Biomerica, Inc. Title of Class of Securities: Common Stock CUSIP Number: 09061H307 Item 1: Reporting Person: Wasatch Advisors LP 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 953,264 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 953,264 Item 8: Shared Dispositive Power: 0 Item 9: Aggregate Amount Owned: 953,264 Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A Item 11: Percent of Class Owned: 5.7% Item 12: Type of Reporting Person: IA Item 1(a): Name of Issuer: Biomerica, Inc. Item l(b): Address of Issuer: 17571 Von Karman Avenue, Irvine, CA 92614 Item 2(a): Name of Person Filing: Wasatch Advisors LP Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108 Item 2(c): Citizenship: Not Applicable Item 2(d): Title of Class of Securities: Common Stock Item 2(e): CUSIP Number: 09061H307 Item 3(e): Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 Item 4(a): Amount Owned: 953,264 Item 4(b): Percent of Class Owned: 5.7% Item 4(c)(i): Sole Voting Power: 953,264 Item 4(c)(ii): Shared Voting Power: 0 Item 4(c)(iii): Sole Dispositive Power: 953,264 Item 4(c)(iv): Shared Dispositive Power: 0 Item 5: Check Box If Ownership Is 5% or Less of Class: [ ] Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A Item 7: Identification of Subsidiary: Not Applicable Item 8: Identification of Members of Group: Not Applicable Item 9: Notice of Dissolution of Group: Not Applicable Item 10: Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as of December 31, 2023. Date: 02/09/24 Signature: /s/JB Taylor Name/Title: JB Taylor/CEO

Get the next $BMRA alert in real time by email

SEC Form SC 13G filed by Biomerica Inc.

2/9/24 3:06:57 PM ET

$BMRA

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Get the next $BMRA alert in real time by email

SEC Form SC 13G filed by Biomerica Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BMRA

SEC Form SC 13G filed by Biomerica Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BMRA

$BMRA
SEC Filings

SEC Form 10-Q filed by Biomerica Inc.

SEC Form S-8 filed by Biomerica Inc.

SEC Form 10-Q filed by Biomerica Inc.

$BMRA
Press Releases

Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs

Biomerica Reports Third Quarter Fiscal 2026 Financial Results

Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe

$BMRA
Insider Trading

Director Chin Eric was granted 22,500 shares, increasing direct ownership by 225% to 32,500 units (SEC Form 4)

Chief Financial Officer Lu Gary was granted 40,000 shares, increasing direct ownership by 206% to 59,375 units (SEC Form 4)

Executive Vice-Chairman Barbieri Allen was granted 30,000 shares, increasing direct ownership by 127% to 53,543 units (SEC Form 4)

$BMRA
Leadership Updates

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

$BMRA
Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by Biomerica Inc.

SEC Form SC 13G/A filed by Biomerica Inc. (Amendment)